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neurologic complications. Propensity score analysis was performed to verify the role of EMB in CBT surgery.
Results: The number of CBT patients and CBT operations rapidly increased in recent years. The population was composed of 132 patients (74 males and 58 females) with 142 CBTs resected. Tumor classification was Shamblin I in 29 tumors, Shamblin II in 61, and Shamblin III in 52. Of these, 97 tumors underwent EMB, and significantly decreased vascularization was achieved in 99.0%. Intraoperatively, rupture of the internal carotid artery occurred in 29 patients (20.4%) and was successfully reconstructed in 28 patients (96.4%) and ligated in one patient (3.6%). After surgery, a transient cranial deficit was identified in 44 patients (31%), and stroke was found in four patients (2.8%). During a mean follow-up of 60.7 months, seven patients (4.9%) were lost to follow-up, and a permanent nerve deficit was found in 18 (13.3%). Multivariate regression analysis revealed that the incidence of neurologic complications was associated with Shamblin group III (P ¼ .005 for in-hospital complication; P ¼ .001 for permanent neurologic complication) and high-lying tumors (P ¼ .047 for in-hospital complication; P ¼ .101 for permanent neurologic complication). In comparison with the non-EMB group, the EMB group did not exhibit decreased rates of in-hospital neurologic complications (9 vs 15; P ¼ .151) or persistent neurologic complications (4 vs 6; P ¼ .502) but had decreased operation times (100.0 minutes vs 183.0 minutes; P < .001) and blood loss (65 mL vs 100 mL; P ¼ .039).
Conclusions: Surgical resection of CBTs is the gold standard. The rate of neurologic complications is acceptable. Shamblin group III and highlying tumors were vulnerable to neurologic complications. EMB did not decrease the risks of neurologic complications, although it decreased operation times and blood loss.
Author Disclosures: J. Li: Nothing to disclose; S. Li: Nothing to disclose; Y. Li: Nothing to disclose; W. Lv: Nothing to disclose; J. Wang: Nothing to disclose; J. Wang: Nothing to disclose; S. Wang: Nothing to disclose; C. Yao: Nothing to disclose.
RS04.

Natural History of Progression of Carotid Artery Stenosis
Ziad Al Adas, Judith Lin, Timothy Nypaver, Mitchell R. Weaver, Alex D. Shepard, Lucy Ching Chau, Daniel Miller, Loay Kabbani. Henry Ford Health System, Detroit, Mich
Objectives: Ipsilateral carotid artery stenosis has been reported as the cause of 10% to 20% of ischemic strokes. The rate of progression of carotid artery stenosis is not clear in the literature, and uncertainty exists regarding the optimal frequency of ultrasound examinations for surveillance of untreated internal carotid artery stenosis. This study was designed to define the natural progression of carotid artery stenosis.
Methods: The vascular laboratory database at our tertiary care referral center was retrospectively analyzed for all carotid duplex studies performed between January 2004 and June 2014. Patients had to have at least two carotid studies more than 6 months apart to be included in the study. Every carotid artery was considered as an individual case. Carotid arteries were grouped by degree of stenosis: grade 1, no plaque up to 20% stenosis; grade 2, 20% to 49% stenosis; grade 3, 50% to 69% stenosis; grade 4, 70% to 90% stenosis; and grade 5, 90% to 99% stenosis. Progression was defined as an increase by any grade of stenosis. Patient demographics and comorbidities were analyzed for risk factors. Data analysis was conducted using SPSS 22.0 software (IBM Corp, Armonk, NY).
Results: During the study period, 43,314 carotid arteries were imaged; of these, 6190 met the inclusion criteria. Average follow-up time was 43 months; average time between examinations was 29 months. Average age was 70 years, 52% were women, 82.5% had grade 1 or 2 stenosis, and 17.5% had grade 3, 4, or 5 stenosis. Only 2.6% of grade 1 arteries and 15% of grade 2 arteries progressed to grade $3. Of those carotid arteries with grade 3, 4, or 5 stenosis, 174 (16.2%) progressed to a higher grade, and average time to progression was 8 years. For grades 3, 4, and 5 stenosis, male sex (P ¼ .023), young age (P ¼ .001), and atrial fibrillation (P ¼ .002) were independent risk factors for progression.
Conclusions: This study documents a relatively slow progression rate for carotid disease. This result calls into question the utility of annual surveillance imaging in patients with carotid stenosis. Clinical criteria are needed to define a high-risk group of patients who might benefit from more frequent imaging.
Author Disclosures: Z. Al Adas: Nothing to disclose; L. Ching Chau: Nothing to disclose; L. Kabbani: Nothing to disclose; J. Lin: Nothing to disclose; D. Miller: Nothing to disclose; T. Nypaver: Nothing to disclose; A. D. Shepard: Nothing to disclose; M. R. Weaver: Nothing to disclose.
VS03.
Giant Carotid Body Tumors
Benjamin W. Starnes, Niten Singh, Basavaraj Ghodke, Kris Moe. University of Washington, Seattle, Wash
Background: This video depicts the successful surgical resection of a giant Shamblin III carotid body tumor with preservation of all cranial nerves and carotid vessels. Exposure and resection technique is emphasized.
http://www.conferenceabstracts.com/uploads/cfp2/attachments/ZRFDQ HCR/ZRFDQHCR-289737-1-ANY.mp4
Author Disclosures: B. Ghodke: Nothing to disclose; K. Moe: Nothing to disclose; N. Singh: Nothing to disclose; B. W. Starnes: AORTICA Corp: intellectual property/patents, ownership interest.
S3: PLENARY SESSION 3
SS12.
Long-Term Outcomes of Indwelling Vena Cava Filters
Eric Hager, Becky Long, Abdallah Naddaf, Larry Fish, Efthymios Avgerinos, Rabih Chaer. University of Pittsburgh, Pittsburgh, Pa
Objectives: This study determined the long-term outcomes of both retrievable and permanent inferior vena cava filters (IVCF).
Methods: An Institutional Review Board-approved retrospective analysis was performed in a multihospital system to identify all patients in whom an IVCF implanted from 2007 to 2012. Patients with <30-day follow-up and patients without imaging were excluded from the study. Inpatient and outpatient images (computed tomography scan, 3-view abdominal x-ray imaging) and encounters were reviewed to determine the clinical outcomes of the IVCF and the structural integrity. Statistical analysis was performed using standard methods.
Results: Over the study period we identified 1112 patients in whom an IVCF was placed. Of these, 510 were retrieved (45.9%). Of the remaining 602 patients, 425 (70.6%) had removable IVCF placed, 103 (17.1%) had permanent IVCF implanted, and 74 (12.3%) patients were lost to follow-up. The mean age of the cohort was 62.8 years. The most common indication for IVCF was deep venous thrombosis with inability to anticoagulate 
